Q2 2025 Holdings
Filed 2025-08-13 | 439 holdings | $295.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $88.7K | 4,220 | 0.0% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $88.7K | 22,177 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $88.7K | 2,729 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $89.2K | 4,017 | 0.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $89.2K | 23,927 | 0.0% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $89.3K | 8,134 | 0.0% |
| Merus N V | COM | N5749R100 | $89.3K | 1,698 | 0.0% |
| Immunome Inc(IMNM) | COM | 45257U108 | $89.3K | 9,605 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $89.3K | 7,329 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $89.5K | 7,862 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $89.7K | 2,867 | 0.0% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $90.0K | 16,792 | 0.0% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $90.1K | 7,178 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $90.3K | 7,955 | 0.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $90.8K | 18,014 | 0.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $90.8K | 4,875 | 0.0% |
| Curevac N V | COM | N2451R105 | $91.2K | 16,792 | 0.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $91.4K | 12,422 | 0.0% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $91.6K | 5,797 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $91.7K | 33,825 | 0.0% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $91.7K | 5,392 | 0.0% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $92.0K | 18,188 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $92.0K | 6,894 | 0.0% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $92.1K | 1,207 | 0.0% |
| CG Oncology Inc(CGON) | COM | 156944100 | $92.2K | 3,548 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $92.3K | 1,670 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $93.1K | 1,414 | 0.0% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $93.2K | 3,179 | 0.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $93.5K | 13,024 | 0.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $93.6K | 2,832 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $93.7K | 1,756 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $93.9K | 9,422 | 0.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $94.0K | 4,621 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $94.3K | 27,256 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $94.4K | 5,899 | 0.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $94.5K | 1,784 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $94.9K | 41,607 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $95.3K | 18,620 | 0.0% |
| Cartesian Therapeutics Inc(RNAC) | COM NEW | 816212302 | $95.4K | 9,183 | 0.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $95.9K | 4,783 | 0.0% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $96.0K | 8,441 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $96.0K | 9,775 | 0.0% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $96.0K | 5,535 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $96.0K | 5,457 | 0.0% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $96.8K | 7,439 | 0.0% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $97.5K | 2,246 | 0.0% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $97.6K | 6,965 | 0.0% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $97.7K | 16,837 | 0.0% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $98.2K | 1,172 | 0.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $98.4K | 4,176 | 0.0% |